🔗 Visit the ClinicalTrials.gov page for NCT00468208
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. | N Engl J Med | 2005 | 6.37 |
| 2 | Etanercept plus standard therapy for Wegener's granulomatosis. | N Engl J Med | 2005 | 5.17 |
| 3 | Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse. | Am J Med | 2003 | 1.03 |
| 4 | Can existing drugs approved for other indications retard renal function decline in patients with type 1 diabetes and nephropathy? | Semin Nephrol | 2012 | 1.02 |
| 5 | Progress in treatment of ANCA-associated vasculitis. | Arthritis Res Ther | 2012 | 0.93 |
| 6 | Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. | Clin Exp Immunol | 2014 | 0.86 |
| 7 | CTLA4-Ig in B7-1-positive diabetic and non-diabetic kidney disease. | Diabetologia | 2015 | 0.76 |